Brevan Howard Capital Management’s Arcturus Therapeutics ARCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12,305	Closed	-$209K	–	1105
2024 Q4	$209K	Buy	12,305 +1,486	+14%	+$25.2K	﹤0.01%	869
2024 Q3	$251K	Buy	+10,819	New	+$251K	﹤0.01%	867
2024 Q1	–	Sell	-6,749	Closed	-$213K	–	955
2023 Q4	$213K	Buy	+6,749	New	+$213K	﹤0.01%	817